Detalles de la búsqueda
1.
Dinuclear gold(I) complexes based on carbene and diphosphane ligands: bis[2-(dicyclohexylphosphano)ethyl]amine complex inhibits the proteasome activity, decreases stem cell markers and spheroid viability in lung cancer cells.
J Biol Inorg Chem
; 28(8): 751-766, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37955736
2.
In Ovarian Cancer Multicellular Spheroids, Platelet Releasate Promotes Growth, Expansion of ALDH+ and CD133+ Cancer Stem Cells, and Protection against the Cytotoxic Effects of Cisplatin, Carboplatin and Paclitaxel.
Int J Mol Sci
; 22(6)2021 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33809553
3.
Analogs of a Natural Peptaibol Exert Anticancer Activity in Both Cisplatin- and Doxorubicin-Resistant Cells and in Multicellular Tumor Spheroids.
Int J Mol Sci
; 22(16)2021 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34445069
4.
CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth.
Haematologica
; 104(3): 564-575, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30309853
5.
Formation of the Immunosuppressive Microenvironment of Classic Hodgkin Lymphoma and Therapeutic Approaches to Counter It.
Int J Mol Sci
; 20(10)2019 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31096713
6.
Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer.
Int J Mol Sci
; 19(5)2018 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29772686
7.
In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability.
Haematologica
; 107(1): 287-291, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34498447
8.
The inflammatory chemokine CCL5 and cancer progression.
Mediators Inflamm
; 2014: 292376, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24523569
9.
In ovarian cancer maraviroc potentiates the antitumoral activity and further inhibits the formation of a tumor-promoting microenvironment by trabectedin.
Biomed Pharmacother
; 172: 116296, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38382330
10.
Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity.
J Cell Biochem
; 114(5): 1135-44, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23192362
11.
Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer.
Gynecol Oncol
; 131(3): 744-52, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24029417
12.
In Doxorubicin-Adapted Hodgkin Lymphoma Cells, Acquiring Multidrug Resistance and Improved Immunosuppressive Abilities, Doxorubicin Activity Was Enhanced by Chloroquine and GW4869.
Cells
; 12(23)2023 11 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38067159
13.
Preclinical activity of the repurposed drug auranofin in classical Hodgkin lymphoma.
Blood
; 126(11): 1394-7, 2015 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26228484
14.
Current and Emerging Approaches to Study Microenvironmental Interactions and Drug Activity in Classical Hodgkin Lymphoma.
Cancers (Basel)
; 14(10)2022 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35626032
15.
Design, Synthesis, and Preclinical Activity in Ovarian Cancer Models of New Phosphanegold(I)-N-heterocyclic Carbene Complexes.
J Med Chem
; 65(21): 14424-14440, 2022 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36278959
16.
Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells.
J Cell Physiol
; 226(8): 2131-8, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21520065
17.
Antitumor activity of gold(III)-dithiocarbamato derivatives on prostate cancer cells and xenografts.
Int J Cancer
; 128(1): 206-15, 2011 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20209498
18.
IRF4 silencing inhibits Hodgkin lymphoma cell proliferation, survival and CCL5 secretion.
Br J Haematol
; 152(2): 182-90, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21114485
19.
The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape.
J Pathol
; 221(3): 248-63, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20527019
20.
Trabectedin overcomes doxorubicin-resistance, counteracts tumor-immunosuppressive reprogramming of monocytes and decreases xenograft growth in Hodgkin lymphoma.
Cancer Lett
; 500: 182-193, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33326840